About Us
Haohai Group, Growing with the Times
Hebei Haohai Pharmaceutical Co., Ltd.
Hebei Haohai Group's predecessor was the Feed and Drug Additives Factory of the College of Fisheries, Hebei Agricultural University (1986). It was established in January 2001 with the strong support of the Provincial Animal Husbandry Bureau, Veterinary Drug Supervision Office, and relevant government departments; In response to the Ministry of Agriculture's requirements for veterinary drug production enterprises to produce in accordance with veterinary drug GMP standards, Haohai Company passed the GMP certification of the Ministry of Agriculture in 2007. Production dosage forms include powders/premixes/powders, insecticides (solid, liquid), disinfectants (solid, liquid), traditional Chinese medicine extraction, microbial fermentation, water quality improvers, etc. After more than ten years of development, it has passed three GMP re-inspections in 2013, 2018, and 2023 respectively. In April 2021, it passed the acceptance project of the Feed Office of the Hebei Provincial Department of Agriculture and Rural Affairs and obtained a production license for mixed feed additives. It is one of the only veterinary drug and animal husbandry dual-certified enterprises in Hebei Province.
Company Founded
Investment of 195 million yuan
Land Area
Partners
Group Environment
Factory gate
Additives workshop
Office building
GMP Zone 2
Disinfectant workshop
Finished Product Inspection Center
Honors and Qualifications
Product Center
Production dosage forms include powders/premixes/powders, insecticides (solid, liquid), disinfectants (solid, liquid), traditional Chinese medicine extraction, microbial preparations, water quality improvers, etc.
Aquaculture Drugs
Livestock Drugs
Poultry and Livestock Drugs
Ruminant Drugs
Pet Drugs
Scientific Research and Innovation
Using Scientific Research as a Blade to Break Through Innovation
R&D Team
> 16 Leading Experts
> 400+ Engineer R&D Team
——
R&D Center
> 168 million yuan in R&D investment in 2022
> 8.08% R&D investment ratio
——
Technology Platform
Laboratory Scale:
> 28,500 square meters
> 36,200 square meters of animal laboratory
> 11,600 square meters of P3 laboratory
> 5 National Innovation Platforms
——
New Veterinary Drug Certificates and Patents
> 107 New Veterinary Drug Registration Certificates
> 6 Internationally First-Created Class I New Veterinary Drugs
> 242 Patents
——
Committed to technological innovation, striving to provide green, environmentally friendly, healthy, and safe products for the aquaculture industry
Several subsidiaries under the Group
Total number of employees in the Group
Aquaculture technical service network points
News Center
Focus on Haohai dynamics, decoding the future of the industry
2025-03-20
Animal welfare medical "needle" wonders
Walking into the construction site of the Hebei Haohai Pharmaceutical Co., Ltd. new project, the sound of machinery roars, tower cranes stand tall, and large machinery such as engineering vehicles and transport vehicles operate simultaneously, presenting a busy scene. The project has a total investment of 109 million yuan and covers a total area of 28 mu. The factory buildings are all designed and constructed according to EU standards, strictly implementing the "three no" production standards of no waste, no wastewater, and no waste gas...With such high standards, what kind of medicine is produced here?
2025-03-20
Pre-filled syringes are for intramuscular injection, offering good efficacy, high safety, and ease of operation. "The product packaging clearly indicates the target diseases and usage methods, allowing for independent purchase as needed. Its promotion and application can make animal disease prevention and treatment more standardized, simpler, and more affordable." Song Qingchun said, "This will be another successful practice of the company's innovative research and development, and it is our 'star' product."
2025-03-20
Project construction is steadily advancing, and new product R&D is strong.
On March 22, reporters saw at the construction site of the new project of Hebei Haohai Pharmaceutical Co., Ltd. that workers were pouring the concrete structure of the first floor of the factory building, and the scene was busy.
2025-03-20
We can treat common diseases of aquatic products such as fish, shrimp, crabs, and turtles, and bacterial diseases of aquatic plants such as kelp and Undaria pinnatifida. Song Qingchun, chairman of Haohai Pharmaceutical, introduced, "Since the company's establishment, we have always focused on animal medicine and aquatic plant care, and our R&D technology and market share have always been at the forefront of the industry."